Article
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Journal of neurology, neurosurgery, and psychiatry - 1 Feb 2022
Peakman Georgia, Russell Lucy L, Convery Rhian S, Nicholas Jennifer M, Van Swieten John C, Jiskoot Lize C, Moreno Fermin, Sanchez-Valle Raquel, Laforce Robert, Graff Caroline, Masellis Mario, Tartaglia Maria Carmela, Rowe James B, Borroni Barbara, Finger Elizabeth, Synofzik Matthis, Galimberti Daniela, Vandenberghe Rik, de Mendonça Alexandre, Butler Chris R, Gerhard Alex, Ducharme Simon, Le Ber Isabelle, Tagliavini Fabrizio, Santana Isabel, Pasquier Florence, Levin Johannes, Danek Adrian, Otto Markus, Sorbi Sandro, Rohrer Jonathan D
Abstract excerpt
BACKGROUND: Therapeutic trials are now underway in genetic forms of frontotemporal dementia (FTD) but clinical outcome measures are limited. The two most commonly used measures, the Clinical Dementia Rating (CDR)+National Alzheimer's Disease Coordinating Center (NACC) Frontotemporal Lobar Degeneration (FTLD) and the FTD Rating Scale (FRS), have yet to be compared in detail in the genetic forms of FTD. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
